Retrograde Tibial Access for Endovascular Treatment of Femoropopliteal Occlusions: Is it a Safe Strategy?

Endovascular recanalization of femoropopliteal occlusions continues to be one of the initial therapeutic strategies to treat this pathology. 

Acceso retrógrado mediante la arteria tibial para el tratamiento de oclusiones en territorio femoropoplíteo: ¿es una estrategia segura?

The anterograde approach via the common femoral is the most frequently used. However, it is not always viable, especially in long occlusions with severe calcification or when the femoral artery cannot be reached. In these cases, the retrograde approach represents a safe and effective strategy. 

The aim of this retrospective, single center study was to assess the safety, efficacy and feasibility of retrograde crossing of femoropopliteal occlusions with tibial access after failed anterograde approach. 

Primary efficacy endpoint was retrograde crossing success rate. secondary efficacy endpoint was technical success rate. Primary safety endpoint was the rate of acute (≤30 days) access site-specific complications. 

Secondary safety endpoints included the rate of major adverse cardiovascular events (MACE) at 30 days (30-day MACE) and the rate of acute (≤30 days) intervention-specific complications.

Primary feasibility endpoint was rate of successful cannulation and sheath introduction. Secondary feasibility endpoints included the cannulation time and the time for hemostasis.

Read also: PICCOLETO-II: balones liberadores de droga en vasos pequeños.

From 2015 to 2022 the study looked at 152 patients. Mean age was 74 and 50.7% were men. The most frequent clinical presentation was resting pain in 67.8% (Rutherford IV), followed by Rutherford III in 22.4% of patients. Mean lesion length was 25 cm, and 45% of cases presented PACSS calcification grade III followed by grade IV in 43%. The proximal tract of the anterior tibial artery was the most used (60.5%), and sheath inductor and cannulation (4Fr in 50.7%) were successful in all cases.  

Rate of retrograde crossing of femoropopliteal occlusions was 94%. As regards Access site related complications within 30 days, these were found in 4.6% of patients. Specific complications associated to the intervention happened in 12.5% of cases. MACE rate was 3.3% and MALE rate (major adverse limb events) was 2%. 

Conclusion

Retrograde crossing of femoropopliteal occlusions with tibial access after anterograde failed approach is feasible, safe and effective. It could be an interesting alternative to combine both these approaches. This calls for further prospective, randomized and multicenter studies with long term follow up. 

Dr. Andrés Rodríguez

Dr. Andrés Rodríguez.
Member of the editorial board of SOLACI.org.

Original Title: Endovascular treatment of femoro‐popliteal occlusions with retrograde tibial access after failure of the antegrade approach.

Reference: Roberto Minici MD et al Catheter Cardiovasc Interv. 2023;1–12.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

EuroSMR Registry: Edge-to-Edge Mitral Treatment with 5-Year Outcomes

Cardiomyopathies and left atrial enlargement can lead to secondary mitral regurgitation (SMR). This condition is associated with ventricular dysfunction, causing heart failure, hospitalization, and...

TricValve Transcatheter Bicaval Valve System for Severe Tricuspid Insufficiency: Events at One Year

TricValve is the first bicaval valve system to obtain CE-Mark approval. This device heterotopic device eliminates tricuspid insufficiency reflux into the venous system, reducing...

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...